News | Neurological conditions

News

Warning over risk of Guillain-Barré syndrome following RSV vaccination

The Medicines and Healthcare products Regulatory Agency said that, as of 2 June 2025, it had received 21 Yellow Card reports of suspected Guillain-Barré syndrome in older adults aged 75–79 years after they received the Abrysvo vaccine.…

Published: 9 July 2025

Opinion

Developing my role as a neuropharmacist to improve care for patients with epilepsy

Advanced neurology pharmacist Olga Tanda shares how she seized the opportunity to lead the outpatient epilepsy clinic at her trust and put patients at the centre of their care.…

Published: 3 July 2025

News

NICE rejects Alzheimer’s disease drugs for third time

The National Institute for Health and Clinical Excellence said the benefits of donanemab and lecanemab in the treatment of Alzheimer's disease are too small to justify their high costs to the NHS.…

Published: 19 June 2025

Feature

Pharmacy Inside Jobs: ADHD assessment and management

In this episode of Pharmacy Inside Jobs, Gurmat Khangura talks about how he has brought his skills and experience as a pharmacist to his role assessing and managing young people with neurodevelopmental conditions.…

Published: 4 June 2025

Opinion

Help us understand current pharmacy practice in migraine management by sharing your experience

Please complete our short survey, which should take no more than seven minutes to complete.…

Published: 21 May 2025

News

Coroner writes to ICB following death of patient who took too many of their prescribed drugs

The ‘Prevention of future deaths’ report, published on 16 April 2025, was issued following the death of patient who was waiting for mental health support.…

Published: 24 April 2025

News

NICE recommends cladribine for treating active relapsing forms of multiple sclerosis

Cladribine (Mavenclad; Merck) is recommended for treating active relapsing-remitting multiple sclerosis in adults when high-efficacy disease-modifying therapies would be offered.…

Published: 17 April 2025

News

Patients in emergency departments should be supported to self-administer time-critical medicines, says royal college

Advice produced with the UK Clinical Pharmacy Association urges that emergency departments should hold self-administered time-critical medicines to the same monitoring and governance oversight standards as non self-administered medicines.…

Published: 7 April 2025

News

Alzheimer’s treatments donanemab and lecanemab still not recommended under latest NICE draft guidance

NICE says that the cost of implementing donanemab and lecanemab across the NHS is “significantly higher” than considered acceptable for taxpayers’ money and NHS resources.…

Published: 11 March 2025

News

First non-cannabis treatment for rare form of epilepsy made available on NHS

Fenfluramine is a non-cannabis treatment for patients with Lennox-Gastaut syndrome who do not respond to existing treatments or clobazam owing to its side effects.…

Published: 20 February 2025